MOBIA MEDICAL, INC. Convertible Notes Payable
MOBIA MEDICAL, INC. (MOBI) had Convertible Notes Payable of $40.00 million as of 2026-03-31, per its 10-Q filed 2026-06-04.
Financial Statements › Balance Sheet › Liabilities
us-gaap:ConvertibleNotesPayable · last filed 2026-06-04
- 2026-03-31: Convertible Notes Payable $40.00M.
| Period end | Convertible Notes Payable |
|---|---|
| 2026-03-31 | $40.00M 10-Q · filed 2026-06-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B |